Clinical Trials Browser

Phase 1/2 × Head and Neck Neoplasms × Celecoxib × Clear all

NCT00970502 2017-04-10

Erlotinib, Celecoxib and Reirradiation for Recurrent Head and Neck Cancer

Phase 1/2 Completed

15 enrolled 16 charts

Head and Neck Neoplasms, Laryngeal Neoplasms, Paranasal Sinus Neoplasms, Pharyngeal Neoplasms

NCT00581971 2013-04-25

RAD0201

Phase 1/2 Completed

30 enrolled 8 charts

Head and Neck Neoplasms, Neoplasms

NCT00357617 2010-12-24

Celecoxib in Treating Patients With Head and Neck Cancer That Can Be Removed By Surgery

Phase 1/2 Unknown

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms